If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2020

Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis

on behalf of TOSCA (Three or Six Colon Adjuvant) Investigators, Jan 1 2020, (Accepted/In press) In : Oncologist.

Research output: Contribution to journalArticle

2019

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y. J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., Sep 1 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183-191.e3

Research output: Contribution to journalArticle

Open Access

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clinical Colorectal Cancer. 18, 3, p. 183

Research output: Contribution to journalArticle

Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP): Clinical Colorectal Cancer

Riechelmann, R. P., Srimuninnimit, V., Bordonaro, R., Kavan, P., Di Bartolomeo, M., Maiello, E., Cicin, I., García-Alfonso, P., Chau, I., Fedyanin, M. Y., Martos, C. F., Ter-Ovanesov, M., Peeters, M., Ko, Y-J., Yalcin, S., Karthaus, M., Aparicio, J., Heinemann, V., Picard, P., Bury, D. & 2 others, Drea, E. & Sobrero, A., 2019, In : Clin Colorectal Cancer. 18, 3, p. 183

Research output: Contribution to journalArticle

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., Mar 29 2019, In : BMC Cancer. 19, 1, 283.

Research output: Contribution to journalArticle

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., Mar 29 2019, In : BMC Cancer. 19, 1, 283.

Research output: Contribution to journalArticle

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., 2019, In : BMC Cancer. 19, 1

Research output: Contribution to journalArticle

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., Mar 29 2019, In : BMC Cancer. 19, 1, p. 1-9 9 p.

Research output: Contribution to journalArticle

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: The ARMANI phase III trial

Di Bartolomeo, M., Niger, M., Morano, F., Corallo, S., Antista, M., Tamberi, S., Lonardi, S., Di Donato, S., Berardi, R., Scartozzi, M., Cardellino, G. G., Di Costanzo, F., Rimassa, L., Luporini, A. G., Longarini, R., Zaniboni, A., Bertolini, A., Tomasello, G., Pinotti, G., Scagliotti, G. & 19 others, Tortora, G., Bonetti, A., Spallanzani, A., Frassineti, G. L., Tassinari, D., Giuliani, F., Cinieri, S., Maiello, E., Verusio, C., Bracarda, S., Catalano, V., Basso, M., Ciuffreda, L., De Vita, F., Parra, H. S., Fornaro, L., Caporale, M., De Braud, F. & Pietrantonio, F., 2019, In : BMC Cancer. 19, 1

Research output: Contribution to journalArticle

Atezolizumab with or without cobimetinib versus regorafenib in previously treated metastatic colorectal cancer (IMblaze370): a multicentre, open-label, phase 3, randomised, controlled trial

Eng, C., Kim, T. W., Bendell, J., Argilés, G., Tebbutt, N. C., Di Bartolomeo, M., Falcone, A., Fakih, M., Kozloff, M., Segal, N. H., Sobrero, A., Yan, Y., Chang, I., Uyei, A., Roberts, L., Ciardiello, F., Ahn, J. B., Asselah, J., Badarinath, S., Baijal, S. & 30 others, Begbie, S., Berry, S., Canon, J. L., Carbone, R. G., Cervantes, A., Cha, Y. J., Chang, K., Chaudhry, A., Chmielowska, E., Cho, S. H., Chu, D., Couture, F., Cultrera, J., Cunningham, D., Van Cutsem, E., Cuyle, P. J., Davies, J., Dowden, S., Dvorkin, M., Ganju, V., Garcia, R. V., Kerr, R., Kim, T. Y., King, K., Kortmansky, J., Lam, K. O., Lee, J., Lee, A. S., Lesperance, B. & Maiello, E., 2019, In : The Lancet Oncology. 20, 6, p. 849-861 13 p.

Research output: Contribution to journalArticle

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

Pietrantonio, F., Lobefaro, R., Antista, M., Lonardi, S., Raimondi, A., Morano, F., Mosconi, S., Rimassa, L., Murgioni, S., Sartore-Bianchi, A., Tomasello, G., Longarini, R., Farina, G., Petrelli, F., Gori, S., Randon, G., Corallo, S., Pagani, F., Guarini, V., Palermo, F. & 11 others, Martinetti, A., Macagno, M., Barault, L., Perrone, F., Tamborini, E., Milione, M., Di Nicolantonio, F., Di Maio, M., Fucà, G., Di Bartolomeo, M. & de Braud, F., Nov 18 2019, In : Clin. Cancer Res..

Research output: Contribution to journalArticle

Capecitabine and Temozolomide versus FOLFIRI in RAS-Mutated, MGMT-Methylated Metastatic Colorectal Cancer

Pietrantonio, F., Lobefaro, R., Antista, M., Lonardi, S., Raimondi, A., Morano, F., Mosconi, S., Rimassa, L., Murgioni, S., Sartore-Bianchi, A., Tomasello, G., Longarini, R., Farina, G., Petrelli, F., Gori, S., Randon, G., Corallo, S., Pagani, F., Guarini, V., Palermo, F. & 11 others, Martinetti, A., Macagno, M., Barault, L., Perrone, F., Tamborini, E., Milione, M., Di Nicolantonio, F., Di Maio, M., Fucà, G., Di Bartolomeo, M. & de Braud, F., Nov 18 2019, In : Clin. Cancer Res.. p. 1-27 27 p.

Research output: Contribution to journalArticle

Comparative effectiveness of gemcitabine plus nab-paclitaxel and folfirinox in the first-line setting of metastatic pancreatic cancer: A systematic review and meta-analysis

Pusceddu, S., Ghidini, M., Torchio, M., Corti, F., Tomasello, G., Niger, M., Prinzi, N., Nichetti, F., Coinu, A., Bartolomeo, M. D., Cabiddu, M., Passalacqua, R., De Braud, F. & Petrelli, F., Apr 2019, In : Cancers. 11, 4, 484.

Research output: Contribution to journalArticle

Open Access

Gastric cancer: Translating novels concepts into clinical practice

Salati, M., Orsi, G., Smyth, E., Aprile, G., Beretta, G., De Vita, F., Di Bartolomeo, M., Fanotto, V., Lonardi, S., Morano, F., Pietrantonio, F., Pinto, C., Rimassa, L., Vasile, E., Vivaldi, C., Zaniboni, A., Ziranu, P. & Cascinu, S., Sep 2019, In : Cancer Treatment Reviews. 79

Research output: Contribution to journalArticle

Gastric cancer: Translating novels concepts into clinical practice

Salati, M., Orsi, G., Smyth, E., Beretta, G., De Vita, F., Di Bartolomeo, M., Fanotto, V., Lonardi, S., Morano, F., Pietrantonio, F., Pinto, C., Rimassa, L., Vasile, E., Vivaldi, C., Zaniboni, A., Ziranu, P. & Cascinu, S., 2019, In : Cancer Treatment Reviews. 79

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

TOSCA (Three or Six Colon Adjuvant) Investigators, Mar 2019, In : The oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Investigators, TOSCA. T. O. S. C. A., Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L. & 20 others, Tronconi, M. C., Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Galli, F. & Di Bartolomeo, M., Mar 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 19 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Di Bartolomeo, M. & Investigators, O. B. O. TOSCA. T. O. S. C. A., 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 19 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Di Bartolomeo, M. & Investigators, O. B. O. TOSCA. T. O. S. C. A., 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 18 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F. & Di Bartolomeo, M., 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 19 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Di Bartolomeo, M. & Investigators, O. B. O. TOSCA. T. O. S. C. A., 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 20 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Galli, F., Di Bartolomeo, M. & Investigators, TOSCA. T. O. S. C. A., Mar 2019, In : The oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., Iaffaioli, R. V., Zampino, M. G., Zaniboni, A., De Placido, S., Banzi, M., Damiani, A., Ferrari, D., Rosati, G., Labianca, R. F., Bidoli, P., Frassineti, G. L., Nicolini, M., Pavesi, L., Tronconi, M. C. & 19 others, Buonadonna, A., Ferrario, S., Re, G. L., Adamo, V., Tamburini, E., Clerico, M., Giordani, P., Leonardi, F., Barni, S., Ciarlo, A., Cavanna, L., Gori, S., Cinieri, S., Faedi, M., Aglietta, M., Antista, M., Dotti, K. F., Di Bartolomeo, M. & Investigators, O. B. O. TOSCA. T. O. S. C. A., Mar 1 2019, In : Oncologist. 24, 3, p. 385-393 9 p.

Research output: Contribution to journalArticle

Individual patient data meta-analysis of the value of microsatellite instability as a biomarker in gastric cancer

Pietrantonio, F., Miceli, R., Raimondi, A., Kim, Y. W., Kang, W. K., Langley, R. E., Choi, Y. Y., Kim, K-M., Nankivell, M. G., Morano, F., Wotherspoon, A., Valeri, N., Kook, M-C., An, J. Y., Grabsch, H. I., Fucà, G., Noh, S. H., Sohn, T. S., Kim, S., Di Bartolomeo, M. & 4 others, Cunningham, D., Lee, J., Cheong, J-H. & Smyth, E. C., 2019, In : Journal of Clinical Oncology. 37, 35, p. 3392-3400 9 p.

Research output: Contribution to journalArticle

Individual Patient Data Meta-Analysis of the Value of Microsatellite Instability As a Biomarker in Gastric Cancer

Pietrantonio, F., Miceli, R., Raimondi, A., Kim, Y. W., Kang, W. K., Langley, R. E., Choi, Y. Y., Kim, K. M., Nankivell, M. G., Morano, F., Wotherspoon, A., Valeri, N., Kook, M. C., An, J. Y., Grabsch, H. I., Fucà, G., Noh, S. H., Sohn, T. S., Kim, S., Di Bartolomeo, M. & 4 others, Cunningham, D., Lee, J., Cheong, J. H. & Smyth, E. C., Dec 10 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 35, p. 3392-3400 9 p.

Research output: Contribution to journalArticle

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Nichetti, F., Falvella, F. S., Miceli, R., Cheli, S., Gaetano, R., Fucà, G., Infante, G., Martinetti, A., Antoniotti, C., Falcone, A., Di Bartolomeo, M., Cremolini, C., de Braud, F. & Pietrantonio, F., Oct 1 2019, In : Pharmacogenomics Journal. 19, 5, p. 465-472 8 p.

Research output: Contribution to journalArticle

Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?

Nichetti, F., Falvella, F. S., Miceli, R., Cheli, S., Gaetano, R., Fucà, G., Infante, G., Martinetti, A., Antoniotti, C., Falcone, A., Di Bartolomeo, M., Cremolini, C., de Braud, F. & Pietrantonio, F., 2019, In : Pharmacogenomics Journal. 19, 5, p. 465-472 8 p.

Research output: Contribution to journalArticle

Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial

Pietrantonio, F., Morano, F., Corallo, S., Miceli, R., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Bergamo, F., Sartore-Bianchi, A., Tampellini, M., Racca, P., Clavarezza, M., Berenato, R., Caporale, M., Antista, M., Niger, M., Smiroldo, V., Murialdo, R., Zaniboni, A. & 10 others, Adamo, V., Tomasello, G., Giordano, M., Petrelli, F., Longarini, R., Cinieri, S., Falcone, A., Zagonel, V., Di Bartolomeo, M. & De Braud, F., Jan 1 2019, In : JAMA oncology.

Research output: Contribution to journalArticle

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial

Pietrantonio, F., Morano, F., Corallo, S., Miceli, R., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Bergamo, F., Sartore-Bianchi, A., Tampellini, M., Racca, P., Clavarezza, M., Berenato, R., Caporale, M., Antista, M., Niger, M., Smiroldo, V., Murialdo, R., Zaniboni, A. & 10 others, Adamo, V., Tomasello, G., Giordano, M., Petrelli, F., Longarini, R., Cinieri, S., Falcone, A., Zagonel, V., Di Bartolomeo, M. & de Braud, F., Jul 3 2019, In : JAMA oncology.

Research output: Contribution to journalArticle

Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial

Pietrantonio, F., Morano, F., Corallo, S., Miceli, R., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Bergamo, F., Sartore-Bianchi, A., Tampellini, M., Racca, P., Clavarezza, M., Berenato, R., Caporale, M., Antista, M., Niger, M., Smiroldo, V., Murialdo, R., Zaniboni, A. & 10 others, Adamo, V., Tomasello, G., Giordano, M., Petrelli, F., Longarini, R., Cinieri, S., Falcone, A., Zagonel, V., Di Bartolomeo, M. & de Braud, F., Jul 3 2019, In : JAMA oncology. 5, 9, p. 1268-1275 8 p.

Research output: Contribution to journalArticle

Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei

Raimondi, A., Corallo, S., Niger, M., Antista, M., Randon, G., Morano, F., Milione, M., Kusamura, S., Baratti, D., Guaglio, M., Cremolini, C., Marmorino, F., Di Bartolomeo, M., Deraco, M., De Braud, F. & Pietrantonio, F., Jun 2019, In : Clinical Colorectal Cancer. 18, 2, p. e179-e190

Research output: Contribution to journalArticle

Negative hyperselection of patients with RAS and BRAF wild-type metastatic colorectal cancer who received panitumumab-based maintenance therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., De Braud, F. & Pietrantonio, F., 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., de Braud, F. & Pietrantonio, F., Nov 20 2019, In : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Open Access

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., de Braud, F. & Pietrantonio, F., Nov 20 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Negative Hyperselection of Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer Who Received Panitumumab-Based Maintenance Therapy

Morano, F., Corallo, S., Lonardi, S., Raimondi, A., Cremolini, C., Rimassa, L., Murialdo, R., Zaniboni, A., Sartore-Bianchi, A., Tomasello, G., Racca, P., Clavarezza, M., Adamo, V., Perrone, F., Gloghini, A., Tamborini, E., Busico, A., Martinetti, A., Palermo, F., Loupakis, F. & 5 others, Milione, M., Fucà, G., Di Bartolomeo, M., de Braud, F. & Pietrantonio, F., Nov 20 2019, In : Journal of Clinical Oncology. 37, 33, p. 3099-3110 12 p.

Research output: Contribution to journalArticle

Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases

Pietrantonio, F., Cotsoglou, C., Fucà, G., Lo Vullo, S., Nichetti, F., Milione, M., Coppa, J., Vaiani, M., Alessi, A., Prisciandaro, M., Droz-Dit Busset, M., Morano, F., Corallo, S., Lazzati, S., Antista, M., Mennitto, A., Randon, G., Raimondi, A., Belfiore, A., Padovano, B. & 5 others, Perrone, F., Mariani, L., Di Bartolomeo, M., de Braud, F. & Mazzaferro, V., Mar 2019, In : Clinical Colorectal Cancer. 18, 1, p. 34-43.e6

Research output: Contribution to journalArticle

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer

Randon, G., Fucà, G., Rossini, D., Raimondi, A., Pagani, F., Perrone, F., Tamborini, E., Busico, A., Peverelli, G., Morano, F., Niger, M., Antista, M., Corallo, S., Saggio, S., Borelli, B., Zucchelli, G., Milione, M., Pruneri, G., Di Bartolomeo, M., Falcone, A. & 3 others, de Braud, F., Cremolini, C. & Pietrantonio, F., Dec 1 2019, In : Scientific Reports. 9, 1, 2858.

Research output: Contribution to journalArticle

Open Access

Prognostic Impact of Microsatellite Instability in Asian Gastric Cancer Patients Enrolled in the ARTIST Trial

Miceli, R., An, J., Di Bartolomeo, M., Morano, F., Kim, S. T., Park, S. H., Choi, M. G., Lee, J. H., Raimondi, A., Fucà, G., Sohn, T. S., Bae, J. M., Kim, S., Lim, D. H., Kang, W. K., Kim, K. M., Pietrantonio, F. & Lee, J., Jul 1 2019, In : Oncology (Switzerland). 97, 1, p. 38-43 6 p.

Research output: Contribution to journalArticle

Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised, placebo-controlled, phase 3 trial

Group, RAINFALL. S., Fuchs, C. S., Shitara, K., Di Bartolomeo, M., Lonardi, S., Al-Batran, S. E., Van Cutsem, E., Ilson, D. H., Alsina, M., Chau, I., Lacy, J., Ducreux, M., Mendez, G. A., Alavez, A. M., Takahari, D., Mansoor, W., Enzinger, P. C., Gorbounova, V., Wainberg, Z. A., Hegewisch-Becker, S. & 31 others, Ferry, D., Lin, J., Carlesi, R., Das, M., Shah, M. A., Luft, A. V., Karaseva, N. A., Kowalyszyn, R. D., Hernandez, C. A., Csoszi, T., De Vita, F., Pfeiffer, P., Sugimoto, N., Kocsis, J., Csilla, A., Bodoky, G., Garnica Jaliffe, G., Protsenko, S., Madi, A., Wojcik, E., Brenner, B., Folprecht, G., Sarosiek, T., Peltola, K. J., Bono, P., Ayala, H., Aprile, G., Gerardo, C. G., Huitzil Melendez, F. D., Falcone, A. & Di Costanzo, F., Mar 1 2019, In : The Lancet Oncology. 20, 3, p. 420-435 16 p.

Research output: Contribution to journalArticle

Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase

Schwartz, S., Szeto, C., Tian, Y., Cecchi, F., Corallo, S., Calegari, M. A., Di Bartolomeo, M., Morano, F., Raimondi, A., Fucà, G., Martinetti, A., De Pascalis, I., Martini, M., Belfiore, A., Milione, M., Orlandi, A., Barault, L., Barone, C., de Braud, F., Di Nicolantonio, F. & 3 others, Benz, S., Hembrough, T. & Pietrantonio, F., 2019, In : European Journal of Cancer. 107, p. 164-174 11 p.

Research output: Contribution to journalArticle

Somatostatin analogs in association with peptide receptor radionucleotide therapy in advanced well-differentiated NETs

Prinzi, N., Raimondi, A., MacCauro, M., Milione, M., Garanzini, E., Torchio, M., Corti, F., Nichetti, F., Russo, G. L., Giacomelli, L., Mazzaferro, V., Bartolomeo, M. D., Seregni, E., Braud, F. D. & Pusceddu, S., Sep 2019, In : Future Oncology. 15, 26, p. 3015-3024 10 p.

Research output: Contribution to journalArticle

The landscape of actionable gene fusions in colorectal cancer

Pagani, F., Randon, G., Guarini, V., Raimondi, A., Prisciandaro, M., Lobefaro, R., Di Bartolomeo, M., Sozzi, G., de Braud, F., Gasparini, P. & Pietrantonio, F., 2019, In : International Journal of Molecular Sciences. 20, 21

Research output: Contribution to journalArticle

The landscape of d16HER2 splice variant expression across HER2-positive cancers

Volpi, C. C., Pietrantonio, F., Gloghini, A., Fucà, G., Giordano, S., Corso, S., Pruneri, G., Antista, M., Cremolini, C., Fasano, E., Saggio, S., Faraci, S., Di Bartolomeo, M., de Braud, F., Di Nicola, M., Tagliabue, E., Pupa, S. M. & Castagnoli, L., Dec 1 2019, In : Scientific Reports. 9, 1, 3545.

Research output: Contribution to journalArticle

Open Access